Wall Street Analysts Think Immunocore (IMCR) Could Surge 65.22%: Read This Before Placing a Bet

Shares of Immunocore Holdings PLC Sponsored ADR (IMCR) have gained 20.2% over the past four weeks to close the last trading session at $36.60, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $60.47 indicates a potential upside of 65.2%.The average comprises 15 short-term price targets ranging from a low of $24 to a high of $100, with a standard deviation of $21.18. While the low ...